Sabrina Paganoni, MD, PhD, co-director, MGH Neurological Clinical Research Institute of Massachusetts General Hospital, was awarded an MDA research grant totaling $500,000 over three years to continue development of the first Platform Trial for ALS. The project will enable ALS researchers at MDA Care Centers and other ALS clinics to conduct clinical trials of more than one drug at a time, as well as test novel indicators of ALS (biomarkers). Dr. Paganoni’s team will work with 54 ALS centers (including 41 MDA Care Centers) and MDA’s innovative MOVR data hub to promote clinical trial recruitment and maximize patient access.

Learn more about this award and other research funding at MDA.org.

More news from the Healey Center for ALS